Kinesin light chain 1 gene haplotypes in three conformational diseases

NeuroMolecular Medicine

Volumn 12, Issue 3, 2010, Pages 229-236

  Von Otter, Malin ^a   Landgren, Sara ^a   Nilsson, Staffan ^b   Lundvall, Caroline ^a   Minthon, Lennart ^c   Bogdanovic, Nenad ^d   Andreasen, Niels ^d   Gustafson, Deborah R ^a   Skoog, Ingmar ^a   Wallin, Anders ^a   Håkansson, Anna ^a   Nissbrandt, Hans ^a   Zetterberg, Madeleine ^a   Tasa, Gunnar ^e   Blennow, Kaj ^a   Zetterberg, Henrik ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UNIVERSITY OF TARTU   (Estonia)

Author keywords

Alzheimer's disease Cataract; Haplotype; Kinesin; KLC1; Parkinson's disease; SNP

Indexed keywords

BIOLOGICAL MARKER; KINESIN; KINESIN LIGHT CHAIN 1; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; CATARACT; CEREBROSPINAL FLUID; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN TRANSPORT; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALZHEIMER DISEASE; CATARACT; ESTONIA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 78649978365     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12017-009-8103-0     Document Type: Article

References (59)

1. Abraham, R., Moskvina, V., et al. (2008). A genome-wide association study for late-onset Alzheimer's disease using DNA pooling. BMC Medical Genomics, 1, 44.
2. Alafuzoff, I., Iqbal, K., et al. (1987). Histopathological criteria for progressive dementia disorders: Clinical-pathological correlation and classification by multivariate data analysis. Acta Neuropathology, 74(3), 209-225.
3. Amaratunga, A., Leeman, S. E., et al. (1995). Inhibition of kinesin synthesis in vivo inhibits the rapid transport of representative proteins for three transport vesicle classes into the axon. Journal of Neurochemistry, 64(5), 2374-2376.
4. Andersson, M. E., Sjolander, A., et al. (2007a). Kinesin gene variability may affect tau phosphorylation in early Alzheimer's disease. International Journal of Molecular Medicine, 20(2), 233-239.
5. Andersson, M. E., Zetterberg, M., et al. (2007b). Variability in the kinesin light chain 1 gene may influence risk of age-related cataract. Molecular Vision, 13, 993-996.
6. Barrett, J. C., Fry, B., et al. (2005). Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics, 21(2), 263-265.
7. Beecham, G. W., Martin, E. R., et al. (2009). Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease. American Journal of Human Genetics, 84(1), 35-43.
8. Bergman, O., Hakansson, A. et al. (2008). PITX3 polymorphism is associated with early onset Parkinson's disease. Neurobiology of Aging doi:10.1016/j.neurobiolaging.2008.03.008.
9. Bertram, L., McQueen, M. B. et al. (2007). Systematic meta-analyses of Alzheimer disease genetic association studies: The AlzGene database. Nature Genetics, 39(1), 17-23. Accessed on Sept. 24, 2009.
10. Bertram, L., Lange, C., et al. (2008). Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. American Journal of Human Genetics, 83(5), 623-632.
11. Bertrand, E., Lechowicz, W., et al. (2003). Degenerative axonal changes in the hippocampus and amygdala in Parkinson's disease. Folia Neuropathologica, 41(4), 197-207.
12. Blennow, K., de Leon, M. J., et al. (2006). Alzheimer's disease. Lancet, 368(9533), 387-403.
13. Blennow, K., Wallin, A., et al. (1995). Tau protein in cerebrospinal fluid: A biochemical marker for axonal degeneration in Alzheimer disease? Molecular and Chemical Neuropathology, 26(3), 231-245.
14. Carrasquillo, M. M., Zou, F., et al. (2009). Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease. Nature Genetics, 41(2), 192-198.
15. Carrell, R. W. (2005). Cell toxicity and conformational disease. Trends in Cell Biology, 15(11), 574-580.
16. Coon, K. D., Myers, A. J., et al. (2007). A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. Journal ofClinical Psychiatry, 68(4), 613-618.
17. Daniel, S. E., & Lees, A. J. (1993). Parkinson's Disease Society Brain Bank, London: Overview and research. Journal of Neural Transmission. Supplementum, 39, 165-172.
18. Dhaenens, C. M., Van Brussel, E., et al. (2004). Association study of three polymorphisms of kinesin light-chain 1 gene with Alzheimer's disease. Neuroscience Letters, 368(3), 290-292.
19. Excoffier, L., & Slatkin, M. (1995). Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Molecular Biology and Evolution, 12(5), 921-927.
20. Falzone, T. L., Stokin, G. B., et al. (2009). Axonal stress kinase activation and tau misbehavior induced by kinesin-1 transport defects. Journal of Neuroscience, 29(18), 5758-5767.
21. Folstein, M. F., Folstein, S. E., et al. (1975). ''Mini-mental state''. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189-198.
22. Frederikse, P. H., Yun, E., et al. (2004). Synapsin and synaptic vesicle protein expression during embryonic and post-natal lens fiber cell differentiation. Molecular Vision, 10, 794-804.
23. Fung, H. C., Scholz, S., et al. (2006). Genome-wide genotyping in Parkinson's disease and neurologically normal controls: First stage analysis and public release of data. Lancet Neurology, 5(11), 911-916.
24. Gabriel, S. B., Schaffner, S. F., et al. (2002). The structure of haplotype blocks in the human genome. Science, 296(5576), 2225-2229.
25. Goldstein, L. S. (2003). Do disorders of movement cause movement disorders and dementia? Neuron, 40(2), 415-425.
26. Grupe, A., Abraham, R., et al. (2007). Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome- wide association study of putative functional variants. Human Molecular Genetics, 16(8), 865-873.
27. Guzik, B. W., & Goldstein, L. S. (2004). Microtubule-dependent transport in neurons: Steps towards an understanding of regulation, function and dysfunction. Current Opinion in Cell Biology, 16(4), 443-450.
28. International HapMap Consortium. (2003). The international HapMap project. Nature, 426(6968), 789-796.
29. Harold, D., Abraham, R., et al. (2009). Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nature Genetics, 41(10), 1088-1093.
30. Hirokawa, N., & Noda, Y. (2008). Intracellular transport and kinesin superfamily proteins, KIFs: Structure, function, and dynamics. Physiological Reviews, 88(3), 1089-1118.
31. Kaether, C., Skehel, P., et al. (2000). Axonal membrane proteins are transported in distinct carriers: A two-color video microscopy study in cultured hippocampal neurons. Molecular Biology of the Cell, 11(4), 1213-1224.
32. Kamal, A., Almenar-Queralt, A., et al. (2001). Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature, 414(6864), 643-648.
33. Kamal, A., Stokin, G. B., et al. (2000). Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. Neuron, 28(2), 449-459.
34. Lambert, J. C., Heath, S., et al. (2009). Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nature Genetics, 41(10), 1094-1099.
35. Lees, A. J., Hardy, J., et al. (2009). Parkinson's disease. Lancet, 373(9680), 2055-2066.
36. Li, H., Wetten, S., et al. (2008). Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Archives of Neurology, 65(1), 45-53.
37. Lill, C. M., Bagade, S. et al. The PDGene Database. Alzheimer Research Forum. Accessed October 7, 2009. Available at: http://www.pdgene.org/.
38. Livak, K. J. (1999). Allelic discrimination using fluorogenic probes and the 5' nuclease assay. Genetic Analysis: Biomolecular Engineering, 14, 143-149.
39. Lo, W. K., Wen, X. J., et al. (2003). Microtubule configuration and membranous vesicle transport in elongating fiber cells of the rat lens. Experimental Eye Research, 77(5), 615-626.
40. Maraganore, D. M., de Andrade, M., et al. (2005). High-resolution whole-genome association study of Parkinson disease. American Journal of Human Genetics, 77(5), 685-693.
41. McCart, A. E., Mahony, D., et al. (2003). Alternatively spliced products of the human kinesin light chain 1 (KNS2) gene. Traffic, 4(8), 576-580.
42. McKhann, G., Drachman, D., et al. (1984). Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34(7), 939-944.
43. Morfini, G., Pigino, G., et al. (2007). 1-Methyl-4-phenylpyridinium affects fast axonal transport by activation of caspase and protein kinase C. Proceedings of the National Academy of Sciences of the United States of America, 104(7), 2442-2447.
44. Pankratz, N., Wilk, J. B., et al. (2009). Genomewide association study for susceptibility genes contributing to familial Parkinson disease. Human Genetics, 124(6), 593-605.
45. Poduslo, S. E., Huang, R., et al. (2009). Genome screen of late-onset Alzheimer's extended pedigrees identifies TRPC4AP by haplo-type analysis. American Journal of Medical Genetics. Part B, Neuropsychiatry genetics, 150B(1), 50-55.
46. Ponce, A., Sorensen, C., et al. (2006). Role of short-range protein interactions in lens opacifications. Molecular Vision, 12, 879-884.
47. Potkin, S. G., Guffanti, G., et al. (2009). Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease. PLoS ONE, 4(8), e6501.
48. Prince, J. A., Feuk, L., et al. (2001). Robust and accurate single nucleotide polymorphism genotyping by dynamic allele-specific hybridization (DASH): Design criteria and assay validation. Genome Research, 11(1), 152-162.
49. Reiman, E. M., Webster, J. A., et al. (2007). GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron, 54(5), 713-720.
50. Roy, S., Zhang, B., et al. (2005). Axonal transport defects: A common theme in neurodegenerative diseases. Acta Neuropathologica, 109(1), 5-13.
51. Srinivasan, B. S., Doostzadeh, J., et al. (2009). Whole genome survey of coding SNPs reveals a reproducible pathway determinant of Parkinson disease. Human Mutation, 30(2), 228-238.
52. Stokin, G. B., Lillo, C., et al. (2005). Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science, 307(5713), 1282-1288.
53. Szolnoki, Z., Kondacs, A., et al. (2007a). A cytoskeleton motor protein genetic variant may exert a protective effect on the occurrence of multiple sclerosis: The janus face of the kinesin light-chain 1 56836CC genetic variant. Neuromolecular Medicine, 9(4), 335-339.
54. Szolnoki, Z., Kondacs, A., et al. (2007b). A genetic variant in cytoskeleton motors amplifies susceptibility to leukoaraiosis in hypertensive smokers: Gene-environmental interactions behind vascular white matter demyelinization. Journal of Molecular Neuroscience, 33(2), 173-179.
55. Szolnoki, Z., Kondacs, A., et al. (2009). Gene-environmental effects behind leukoaraiosis: A silent genetic variant of the kinesin protein can be activated in a subject with poorly controlled long-lasting hypertension. Clinical Biochemistry, 42(7-8), 630-633.
56. Utton, M. A., Noble, W. J., et al. (2005). Molecular motors implicated in the axonal transport of tau and alpha-synuclein. Journal of Cell Science, 118(Pt 20), 4645-4654.
57. Vanderstichele, H., Van Kerschaver, E., et al. (2000). Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma. Amyloid, 7(4), 245-258.
58. Vanmechelen, E., Vanderstichele, H., et al. (2000). Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: A sandwich ELISA with a synthetic phosphopeptide for standardization. Neuroscience Letters, 285(1), 49-52.
59. Westerlund, M., Belin, A. C., et al. (2008). Cerebellar alpha-synuclein levels are decreased in Parkinson's disease and do not correlate with SNCA polymorphisms associated with disease in a Swedish material. FASEB Journal, 22(10), 3509-3514.